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A 41-year-old uremic woman was presented to the emergency
department with a 2-day history of painless cloudy peritoneal
effluent (Figure 1). She had been undergoing continuous
ambulatory peritoneal dialysis for 2 weeks due to end-stage
Chinese herbs nephropathy, using 2-l exchanges four times
daily with standard 1.5% dextrose dialysate solution. On
examination, physical findings were unremarkable except mild
epigastric tenderness. Laboratory studies showed hemoglobin
9.6 g per 100 ml, leukocyte count 6.17 103/ml, albumin 3.9 g
per 100 ml, lactate dehydrogenase 110 IU/l, and normal liver
function and lipid profile. A serum-to-ascites albumin gradient
was 0.8 g per 100 ml. Analyses of the turbid peritoneal effluent
yielded elevated triglyceride concentration (251 mg per 100 ml)
without evidence of microorganisms or cellular components,
suggestive of chylous ascites. On reviewing her current
medications, she had been prescribed lercanidipine 10 mg
once daily 3 days ago. After discontinuation of lercarnidipine,
the dialysis effluent cleared within 24 h. Re-challenge with
lercarnidipine provoked the same adverse reaction within
16 h. Dihydropyridine calcium channel blockers have been
rarely associated with chylous ascites in peritoneal dialysis
patients; the mechanism is unknown. Other reported etiologies
of nontraumatic chylous effluent include abdominal neoplasm
(lymphoma, solid cancers, and carcinoid tumors), cirrhosis of
liver, infection (tuberculosis and filariasis), inflammation
(radiation, sarcoidosis, retroperitoneal fibrosis, pancreatitis,
and Whipple’s disease), dilated cardiomyopathy, nephrotic
syndrome, and congenital lymphatic abnormalities.
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Figure 1 | Chylous peritoneal dialysis effluent.
868 Kidney International (2009) 75, 868
